The Model Gap
The answer to this question lies in the development of accurate laboratory-based models that recapitulate the various genetic events in human cancer. With such models researchers can understand how they cause cancer and rationally design novel drugs that target them.
GENESIS confers the ability to rapidly introduce subtle, yet highly significant ‘gain-of-function’ disease mutations (common in many forms of cancer), as well as loss-of-function alterations, into any endogenous gene loci of human cells; thus accurately and definitively modeling real patient genotypes.
Click on the image to enlarge.
By enabling the key genetic variations that define a patient genotype to be routinely engineered in a human cell, the model gap is bridged and a means to the implementation of improved drug discovery paradigms that will better target the genetic make-up of individual cancer patients is at hand.
Meet The X-MAN